MOG antibody-associated disease presenting with tumefactive lesions and closed-ring enhancement

Acta Neurol Belg. 2022 Apr;122(2):551-553. doi: 10.1007/s13760-021-01695-1. Epub 2021 May 25.

Authors

Yin-Xi Zhang¹, Yang Zheng¹, Meng-Ting Cai¹, Qiang Du¹, Mei-Ping Ding²

Affiliations

¹ Department of Neurology, Second Affiliated Hospital, School of Medicine, Zhejiang University, 88 Jiefang Road, Hangzhou, 310009, China.
² Department of Neurology, Second Affiliated Hospital, School of Medicine, Zhejiang University, 88 Jiefang Road, Hangzhou, 310009, China. dmp-neurology@zju.edu.cn.

PMID: 34033059
DOI: 10.1007/s13760-021-01695-1

No abstract available

Keywords: Closed-ring enhancement; Myelin oligodendrocyte glycoprotein antibody; Tumefactive demyelinating lesion.

Publication types

Letter

MeSH terms

Antibodies*
Autoantibodies*
Humans
Myelin-Oligodendrocyte Glycoprotein

Substances

Antibodies
Autoantibodies
Myelin-Oligodendrocyte Glycoprotein